18th Earth Science Olympiad in China: Ludhiana boy Rayansh Gupta bags hold, Union ministry hails achievement
Gupta, a Class 12 student at Sat Paul Mittal School, Dugri, Ludhiana, represented India with distinction.
The Union Ministry of Earth Sciences (MoES), Government of India, shared the development on its official Facebook page, stating: 'India's Young Scientists Shine at IESO 2025! Team MoES is proud to announce that Team India has won 7 medals and 1 special award at the 18th International Earth Science Olympiad (IESO 2025) held in Jining, China. Medal Tally & Awards: Rayansh Gupta – 1 Gold, 1 Silver & 1 GYM Reporter Award; Bains Charuvrat – 2 Silver, 1 Bronze; Apam Nidhi Pandey – 1 Silver; Pryanshi Ghanghas – 1 Bronze.'
The Ministry further noted that the Indian team competed against 31 countries, including the USA, Germany, and Australia.
'Competing against 31 countries, including the USA, Japan, China, Germany, Australia, and others, our young scientists showcased brilliance in individual and group events (ITFI, ESP). Supported by the Ministry of Earth Sciences (MoES), this achievement highlights India's growing strength in science education, research, and innovation. Heartiest congratulations to Team India and their mentors,' the Ministry wrote.
Rayansh's mother, Shiffali Gupta, told The Indian Express: 'After successfully clearing Round 1 and Round 2 of the Earth Science Olympiad, Rayansh was selected as one of four students to represent India on the international stage in China. Before their departure, the team underwent a week-long training camp in Chennai. In a moment of great pride for us, Rayansh was appointed captain of the Indian team and had the honor of holding the national flag at the final round.'
'We are delighted to share that Rayansh Gupta has brought immense pride to our school by representing India at the 18th International Earth Science Olympiad held in China. Supported by the Ministry of Earth Sciences, this achievement highlights India's growing strength in science education, research, and innovation,' read a statement from the school.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
27 minutes ago
- Hindustan Times
Japan's Takeda weighs India for global trials to speed up drug launches
By Rishika Sadam and Bhanvi Satija Japan's Takeda weighs India for global trials to speed up drug launches -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting global clinical trials in India to accelerate the launch of its innovative drugs in the world's most populous nation, its India head told Reuters. The plan comes at a time when India's clinical trials market is growing, powered by diverse patient pools, cost efficiency, and a fast-growing hospital network. Grand View Research expects the market to exceed $2 billion by 2030. "India is a strategic growth market for Takeda, and we are making significant long-term investments... in terms of innovation and building capabilities," said Annapurna Das, the general manager of Takeda's India operations. She did not share financial details of the investments. "We're exploring the opportunity of leveraging India's clinical trial ecosystem," Das said. Takeda is also open to partnering with local academia, healthcare providers and technology firms in India for innovation, Das said, without sharing more specifics. "At this point of time, we are still kind of exploring and evaluating how we want to go ahead," she added. Takeda's eventual aim is to integrate India's research and development "ecosystem" into its global pipeline and expand Indian patients' access to cutting-edge therapies in oncology, neuroscience, gastrointestinal health, and inflammation. The Japanese drugmaker aims to launch key cancer drugs over the next two to three years in India, with a lung cancer drug ready to hit the market this year. There's also a dengue vaccine in its launch pipeline, for which Takeda has tied up with local vaccine maker Biological E., and is awaiting approval from India's drug regulator. Takeda established an innovation centre in Bengaluru, dubbed India's "Silicon Valley", earlier this year to tap the country's tech talent to power its global digital transformation. The centre is expanding to have 750 staff working in AI, data science, engineering, and design, from just over 500 employees currently. This article was generated from an automated news agency feed without modifications to text.
NDTV
an hour ago
- NDTV
Early Puberty, Childbirth Linked To Faster Ageing, High Diabetes Risk: Study
When puberty begins very early or a first baby arrives in the late teens, it can feel like life is simply running ahead of schedule. New research suggests the body may be doing the same when women go through these life and health landmarks early: ageing faster under the hood. A recently published study in eLife reports that early menarche (first period) and childbirth before 21 are associated with accelerated biological ageing and sharply higher risks of age-related diseases. Conversely, later puberty and later first birth were linked with slower epigenetic ageing, lower frailty, and reduced risk of conditions like type 2 diabetes and Alzheimer's disease. The findings, based on large-scale genetic and cohort analyses, build on a growing body of evidence that reproductive milestones can influence lifelong metabolic and cardiovascular health. For Indian readers, especially women, this matters. India now has an estimated 101 million people living with diabetes and 136 million with prediabetes, many of them women balancing work, family and caregiving. Understanding how reproductive timing intersects with long-term risk can help women and clinicians plan screening, prevention and support without stigma or blame. What Did The New Study Find? Researchers analysed data from hundreds of thousands of participants and used genetic approaches to reduce confounding, concluding that early menarche (before approximately 11 years) and early childbirth (before 21 years) are linked to faster biological or "epigenetic" ageing and substantially higher odds of several age-related diseases. In the UK Biobank subset, the authors report that early menarche and early first birth almost doubled the risk of type 2 diabetes and heart failure and quadrupled the risk of obesity; later timing showed the opposite pattern of slower ageing and lower disease risk. These results are consistent with an "antagonistic pleiotropy" idea: traits that support early reproduction may carry long-term health costs. Independent, recent evidence supports the link between reproductive events and ageing biology. For example, a 2024 study published in PNAS found pregnancy was associated with "older" biological signatures on certain epigenetic measures, while broader research connects epigenetic age acceleration with chronic disease and functional decline. Together, these strands point to a real, measurable interface between reproductive history and later-life health. Why This Matters For Women's Health In India India is grappling with a high and rising metabolic disease burden. The ICMR-INDIAB analysis estimated 101 million with diabetes and 136 million with prediabetes in 2023-figures with clear implications for screening and prevention among women across the life course. If early puberty and early childbirth amplify future metabolic and cardiac risk, earlier and more proactive monitoring becomes essential. There are also population trends to consider. Nationally representative analyses, especially one published in Scientific Reports in 2024, show the mean age at menarche in India is about 13.5 years, with a gradual secular decline across birth cohorts-meaning some girls are entering puberty earlier than previous generations. While early menarche is not destiny, its association with later risk highlights the importance of adolescent nutrition, physical activity, psychosocial support and timely sexual-reproductive health counselling. For young women who become mothers in their teens, even late teens, the new findings argue for stronger postpartum follow-up, diabetes and lipid screening, and support to maintain heart-healthy behaviours while juggling childcare, work and study. How Could Early Reproductive Timing Influence Disease Risk? Scientists increasingly look at epigenetic ageing clocks, the chemical tags on DNA that track biological wear-and-tear. Stressors such as rapid developmental change, pregnancy, under-nutrition or psychosocial adversity may accelerate these clocks in some contexts. Early reproductive events might therefore "pull forward" biological ageing, interacting with well-known drivers like diet quality, physical inactivity, sleep debt, tobacco exposure and air pollution. The result is a higher lifetime probability of metabolic and cardiovascular disease-particularly without regular screening and risk-factor control. Help young girls and women understand their medical history and why it matters Photo Credit: Pexels What Every Woman Should Note: Practical Takeaways Whenever a new study comes out claiming findings that may have long-term impact on public health, it is natural for readers to get alarmed. However, it is very important that Indian women take note of this study and take the following practical takeaways: This is risk, not fate Early periods or a first baby in the teens does not doom anyone to diabetes or heart disease. It signals a need for closer prevention and screening methods which work. Lifestyle changes and evidence-based care can substantially reduce risk. Know your numbers-regularly If you had early menarche or gave birth before 21, ask your clinician about earlier and periodic screening: fasting glucose or HbA1c, blood pressure, lipids, BMI/waist, and (if pregnant now or planning) screening for gestational diabetes. Given India's burden, routine checks from your mid-20s onward are reasonable, or sooner if you have weight gain, strong family history or symptoms. Prioritise cardio-metabolic habits Aim for 150-300 minutes/week of moderate activity plus muscle-strengthening twice weekly; build vegetable-rich, fibre-forward plates with adequate protein; limit ultra-processed foods and added sugars; sleep 7-9 hours; avoid or stop smoking; and reduce second-hand smoke exposure. These steps delay biological ageing patterns and cut diabetes/CVD risk. Pregnancy planning and postpartum care matter If you had a teen pregnancy or gestational diabetes, discuss postpartum glucose testing and long-term follow-up. Evidence shows pregnancy can shift epigenetic ageing markers; checking in after delivery protects future health. Support adolescents For parents and educators, provide balanced nutrition, physical activity, iron sufficiency, mental-health support, and age-appropriate reproductive education. Earlier menarche trends make these investments even more important. There are also some important caveats everyone should note: Association vs causation: The eLife paper used genetic and observational methods to strengthen causal inference, yet unmeasured factors can remain. Findings should guide screening and prevention, not stigma. Population differences: Much evidence comes from cohorts such as UK Biobank; translation to all Indian sub-populations requires local studies. Still, given India's diabetes prevalence, a prudent, preventive approach is justified. Biology is modifiable: Epigenetic ageing markers are not fixed. Lifestyle change, appropriate therapy for blood sugar and blood pressure, and mental-health support can improve long-term outcomes. The new analysis adds a compelling chapter to women's health: earlier puberty and early childbirth appear to accelerate biological ageing and raise risks for diabetes, heart failure and obesity, while later timing generally protects. For Indian women, the message is empowering, not alarming. Know your reproductive history, screen earlier if you're higher-risk, and double down on everyday prevention. Those steps, sustained over years, are powerful tools to bend the risk curve in your favour.
Hans India
4 hours ago
- Hans India
TG attracted Rs 54,000 crore investments in life sciences: Sridhar Babu
Hyderabad: State IT and Industries Minister Duddilla Sridhar Babu announced that the Life Sciences sector in Telangana has witnessed remarkable growth. Since December 2023, the sector has attracted investments worth Rs 54,000 crore, positioning Hyderabad as a global leader in life sciences. The Minister chaired the 6th Board Meeting of the Telangana Life Sciences Foundation in Hyderabad on Wednesday, in his capacity as Chairman. Board members including Dr. Reddy's Laboratories Chairman Satish Reddy, Laurus Labs ED & CEO Dr. Satyanarayana Chava, Special Chief Secretary Sanjay Kumar, and Shakti Nagappan participated in the meeting. Sridhar Babu highlighted that over 2 lakh new jobs have been created in pharmaceutical manufacturing, medical technology, and vaccine production. 'Hyderabad now ranks among the world's top seven life sciences clusters, and it is the only Indian city to achieve this distinction,' he said. He noted that global giants such as Lilly, Amgen, MSD, Zoetis, Evernorth, and Olympus have chosen Hyderabad as their preferred hub. Telangana will soon unveil its Next-Gen Life Sciences Policy, which he described as 'a cutting-edge policy framework designed to attract large-scale investments.' The state has set an ambitious target to scale its Life Sciences economy to USD 250 billion by 2030, aiming to make Telangana the Life Sciences Capital of Asia. The Minister further proposed preparing a feasibility report for establishing the Telangana School of Life Sciences.
